Innovative, High Quality Vaccine Production with GEA Technology

Product description

Pharmaceutical biotechnology requirements are high, including aseptic process management, optimum cleaning capability, closed product handling, compliance with GMP requirements, gentle product treatment, the efficient recovery of active ingredients and reliable scale-up. With technology and equipment designed specifically for this sector, GEA stands for total compliance with these requirements. A critical factor underlying the success of the company is its ability to swiftly translate new developments into marketable processes and systems that fully meet the complex requirements of biotechnological procedures. With standalone machines or package units that guarantee a high yield of valuable substances and operate trouble-free, efficiently, reliably and economically throughout a long service life, GEA has developed numerous innovative improvements to vaccine production processes and brought them to the global market by applying first-class engineering.
Read more


Categories BiopharmaceuticalsBiopharmaceuticals (general category); APIs (Active Pharmaceutical Ingredients)Sera and Vaccines
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from GEA Group

View all our products (12)

Products from other suppliers